Clinical Trial Update: Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial update showing the efficacy and safety of recombinant human epidermal growth factor (rhEGF) for diabetic foot ulcers in patients with uncontrolled…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer

Drugs mentioned

• rhEGF (recombinant human epidermal growth factor)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Diabetic Foot Ulcer Patients With Uncontrolled Diabetes Mellitus | Phase 3 | Status: COMPLETED